Page 2 - Discovery Platform News Today

NEEDHAM, Mass., Feb. 13, 2024 -- Candel Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer,...

Snippets from Nature’s past. Snippets from Nature’s past.

Research-Track Faculty job in Columbus, Ohio with The Ohio State University Comprehensive Cancer Center. Apply Today.

NEEDHAM, Mass., Dec. 12, 2023 -- Candel Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer,...

New Investor Ideas in Biotech (Nasdaq: CADL) (NASDAQ: PPBT) (Nasdaq: RYZB) (Nasdaq: HOWL)

Unification of science and technology is playing a pivotal role in making drug discovery services more efficient. To accelerate its Discovery programs, JB is actively participating in specific initiatives, including the development of a hybrid AI/ML Drug Discovery Platform which brings together a specialized team of professionals from both the IT and scientific sectors – ...

Unification of science and technology is playing a pivotal role in making drug discovery services more efficient. To accelerate its Discovery programs, JB is actively participating in specific initiatives, including the development of a hybrid AI/ML Drug Discovery Platform which brings together a specialized team of professionals from both the IT and scientific sectors – ...

Samsung: Roon will operate as a standalone Harman business with its existing team, and all Roon operations will stay in place, Stamford, Connecticut-headquartered Harman said.

The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate innate immune surveillanceApplication of the...

Initial positive interim data revealed notable improvements in patients with borderline resectable pancreatic ductal adenorcarcinoma after experimental treatment with CAN-2409 Estimated overall...